Stocks Hitting 52-Week Lows

Ariad Pharmaceuticals

shares reached a new 52-week low of $2.735 after the company announced discontinuation of the Phase 3 EPIC trial of Iclusig. Acacia Research

shares dropped 22.91% to touch a new 52-week low of $15.13 after the company reported Q3 results. Stephens downgraded the stock from Overweight to Underweight. Western Refining Logistics LP

shares touched a new 52-week low of $23.45. Western Refining's trailing-twelve-month revenue is $4.19 million. Crestwood Midstream LP

shares reached a new 52-week low of $20.97 after the company announced a public offering of common units.